Evidence map›Paper›PMID 12807961›Full record

ArticleJournal of medical genetics2003

Gene expression signatures identify novel regulatory pathways during murine lung development: implications for lung tumorigenesis.

A E Bonner, W J Lemon, M You

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Journal of medical genetics, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 75 citations in OpenAlex.

  1. EmergingGenes · 2020
    Review
  2. Review
  3. Time-resolved proteome profiling of normal lung development.American journal of physiology. Lung cellular and molecular physiology · 2018
    Article
  4. Article
  5. Regulation of alveolar septation by microRNA-489.American journal of physiology. Lung cellular and molecular physiology · 2016
    Article
  6. Article
  7. Article
  8. Article
  9. The genome-wide transcriptional response to neonatal hyperoxia identifies Ahr as a key regulator.American journal of physiology. Lung cellular and molecular physiology · 2014
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Neutral sphingomyelinase 2 deficiency is associated with lung anomalies similar to emphysema.Mammalian genome : official journal of the International Mammalian Genome Society · 2012
    Article
  16. Article
  17. Article
  18. Article
  19. Transcriptomic analysis of human lung development.American journal of respiratory and critical care medicine · 2010
    Article
  20. Lung cancer: developmental networks gone awry?Cancer biology & therapy · 2009
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

A E BonnerDivision of Human Cancer Genetics, The Ohio State University Comprehensive Cancer Center, 420 West 12th Avenue, Columbus, Ohio 43210, USA.
W J Lemon
M You
Cancer Genetics (United States) · USWashington University in St. Louis · US

Funding

MOLECULAR GENETICS OF MOUSE LUNG TUMORSR01CA058554 · NCI · WASHINGTON UNIVERSITY · PI YOU, MING · 1998 to 2009
$2.3M
GENETIC RESISTANCE TO MOUSE LUNG CARCINOGENESISR01CA078797 · NCI · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI WANG, YIAN · 1998 to 2002
$778k
NCI NIH HHS R01CA58554NCI NIH HHS R01CA78797
6 · The paper itself

Abstract

Oligonucleotide array based analysis was conducted to examine the temporal pattern of gene expression across the various stages of lung development to identify regulatory pathways at key developmental time points. Whole embryo total RNA or embryonic lung total RNA was harvested from A/J mice at seven developmental stages. To investigate changes in gene expression during lung development, four samples from each stage were examined using Affymetrix U74Av2 murine oligonucleotide microarrays. From the over 12,000 genes and ESTs represented on the array, 1346 genes and ESTs were identified as having a significant change in expression between at least one time point and the others (p<0.001, Kruskal-Wallis test). Within this group of approximately 1300 genes, four patterns of expression were seen: (1) upregulation during the embryonic period of development (up-down); (2) upregulation during the postnatal period of lung development (down-up) and (3) fluctuating expression, up initially, down for one or more time points, and then up again (up-down-up); and (4) vice versa (down-up-down). Expression patterns of genes previously reported to be involved in pulmonary development were also examined. Using the pathway visualisation tool, GenMapp, at least three regulatory pathways were found to contain clusters of differentially expressed genes: Wnt signalling, cell cycle, and apoptosis. Furthermore, we have shown that many of the genes involved in lung development are either known oncogenes or tumour suppressor genes altered in lung cancer, such as Cyr61, Rassf1a, and Dutt1/Robo1, or putative lung cancer genes. In addition, the genes identified pertinent to early development may also serve as candidate susceptibility genes for various inherited lung cancer disorders as well as for various heritable disorders of lung development. These results will contribute to our understanding of novel aspects of the regulatory machinery for embryonic lung development and of the genes involved in lung tumorigenesis.

Indexed as

Gene Expression ProfilingOligonucleotide Array Sequence AnalysisAnimalsAnimals, NewbornApoptosisFemaleGene Expression Regulation, DevelopmentalGene Expression Regulation, NeoplasticGenes, NeoplasmLungLung NeoplasmsMiceMice, Inbred APregnancySignal TransductionTime Factors

Identifiers

PMID12807961
PMCPMC1735509
OpenAlexW2164975531

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.